Last reviewed · How we verify

Influenza vaccine GSK2186877A — Competitive Intelligence Brief

Influenza vaccine GSK2186877A (Influenza vaccine GSK2186877A) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Influenza vaccine. Area: Immunology.

phase 3 Influenza vaccine Immunology Biologic Live · refreshed every 30 min

Target snapshot

Influenza vaccine GSK2186877A (Influenza vaccine GSK2186877A) — GlaxoSmithKline. GSK2186877A is an investigational influenza vaccine designed to stimulate immune responses against influenza virus through antigen presentation and adaptive immunity.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Influenza vaccine GSK2186877A TARGET Influenza vaccine GSK2186877A GlaxoSmithKline phase 3 Influenza vaccine
Standard-Dose Influenza Vaccine Standard-Dose Influenza Vaccine Tor Biering-Sørensen marketed Inactivated influenza vaccine
Standard Dose Quadrivalent Influenza Vaccine Standard Dose Quadrivalent Influenza Vaccine Hospital Israelita Albert Einstein marketed Inactivated influenza vaccine
Quadrivalent Influenza Virus Split Vaccine Quadrivalent Influenza Virus Split Vaccine Shanghai Institute Of Biological Products marketed Inactivated split influenza vaccine
Influenza Fluzone vaccine Influenza Fluzone vaccine La Jolla Institute for Immunology marketed inactivated influenza vaccine
FluarixTM FluarixTM GlaxoSmithKline marketed inactivated influenza vaccine
TIV TIV Folia Biotech Inc. marketed Inactivated influenza vaccine

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Influenza vaccine class)

  1. GlaxoSmithKline · 8 drugs in this class
  2. Sanofi Pasteur, a Sanofi Company · 2 drugs in this class
  3. Seqirus · 2 drugs in this class
  4. MedImmune LLC · 1 drug in this class
  5. AstraZeneca · 1 drug in this class
  6. Novartis · 1 drug in this class
  7. Protein Sciences Corporation · 1 drug in this class
  8. ModernaTX, Inc. · 1 drug in this class
  9. Institute of Vaccines and Medical Biologicals, Vietnam · 1 drug in this class
  10. Janssen Vaccines & Prevention B.V. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Influenza vaccine GSK2186877A — Competitive Intelligence Brief. https://druglandscape.com/ci/influenza-vaccine-gsk2186877a. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators: